市場調査レポート

商品コード

1625479

自己免疫疾患診断市場、規模、シェア、動向、産業分析レポート：製品タイプ別、検査タイプ別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 120 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 610,172円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 753,742円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 897,312円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Researchの最新調査によると、世界の自己免疫疾患診断の市場規模は、2034年までに71億4,632万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

自己免疫疾患診断市場は、ヘルスケアおよび診断業界の一分野です。同市場は、高度な診断ツールや技術による自己免疫疾患の特定と管理に焦点を当てています。自己免疫疾患は、免疫系が身体の組織を攻撃することで発症し、慢性的かつ潜在的なさまざまな症状を引き起こします。同市場は、血液検査、画像診断技術、分子アッセイなど、これらの状態を検出するために使用される診断検査や技術を包括しています。

自己免疫疾患の世界の有病率の増加により、早期かつ正確な診断ツールに対する需要が高まっています。これらの疾患に対する認識が高まるにつれ、患者やヘルスケアプロバイダーはより正確で効率的な診断ソリューションを求めるようになっています。さらに、個別化医療や先進的治療アプローチの採用が増加しているため、正確な診断が必要となり、市場の成長をさらに後押ししています。自己免疫疾患と診断の研究に対する政府のイニシアチブと資金援助は、新しい診断方法の開発に貢献しており、それによって市場機会を高めています。

2021年、AMP（Accelerating Medicines Partnership）プログラムは、AMP AIM（Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases）プログラムを導入しました。AMP Autoimmune and Immune-Mediated Diseases（AMP AIM）イニシアチブは、自己免疫疾患に対する認識を高め、早期スクリーニングを促進することで市場を牽引しています。

自己免疫疾患診断市場は、より高い精度と迅速な結果を提供する高度で自動化された診断ソリューションへの迅速な移行を経験しています。人工知能（AI）と機械学習（ML）の診断プラットフォームへの統合は、自己免疫疾患の検出とモニタリング方法を変革し、効率と精度を向上させています。さらに、従来の方法よりも患者に優しい非侵襲的な診断技術の開発にますます注目が集まっています。

2022年7月、KSL Beutner Laboratories（Beutner）は、米国で間接免疫蛍光（IIF）血清血液検査を開始したと発表しました。この検査は、持続性自己免疫疾患である粘膜類天疱瘡（MMP）に関連する抗原であるラミニン332を効果的に検出します。こうした診断法の発展が、自己免疫疾患診断市場の成長を牽引しています。

自己免疫疾患診断市場のレポートハイライト

タイプ別では、主にヘルスケアプロバイダーと患者における認知度の向上により、全身性自己免疫疾患診断セグメントが自己免疫疾患診断市場の売上高シェアを独占しています。

検査タイプ別では、自己免疫疾患の有病率の増加と診断技術の進歩により、抗核抗体（ANA）検査分野が予測期間中に最も高いCAGRを記録する見込みです。

北米は、高度なヘルスケアインフラと医療研究開発のための多額の資金により市場を独占しています。

アジア太平洋は、中国やインドなどの国々の医療セクターの成長と自己免疫疾患の有病率の増加により、予測期間中に最も高いCAGRを記録すると予想されます。

世界の主な市場参入企業は、Abbott、AESKU.DIAGNOSTICS、Beckman Coulter、BIOMERIEUX、Bio-Rad Laboratories、EUROIMMUN、F. Hoffmann-La Roche Ltd、Inova Diagnostics（Werfen Group）、Myriad Genetics、Quest Diagnostics、Scipher Medicine、Siemens Healthcare Private Limited、Thermo Fisher Scientific Inc.などです。

タイプスナップショット
自己免疫疾患診断市場力学
- 促進要因と機会
  - 意識向上とスクリーニングプログラムの強化
  - ヘルスケア支出と調査への投資の増加
抑制要因と課題
PESTEL分析
自己免疫疾患診断市場のタイプ動向
バリューチェーン分析
COVID-19の影響分析

第5章世界の自己免疫疾患診断市場：製品別

主な調査結果
イントロダクション
消耗品・アッセイキット
機器

第6章世界の自己免疫疾患診断市場：タイプ別

主な調査結果
イントロダクション
全身性自己免疫疾患の診断
局所的自己免疫疾患の診断

第7章世界の自己免疫疾患診断市場：検査タイプ別

主な調査結果
イントロダクション
抗核抗体（ANA）検査
自己抗体検査
全血球数（CBC）
包括的代謝パネル
C反応性タンパク質（CRP）
その他

第8章世界の自己免疫疾患診断市場：エンドユーザー別

主な調査結果
イントロダクション
病院
診断センター
研究室

第9章世界の自己免疫疾患診断市場：地域別

主な調査結果
イントロダクション
- 自己免疫疾患診断市場評価：地域別、2020年～2034年
北米
- 北米：製品別、2020年～2034年
- 北米：タイプ別、2020年～2034年
- 北米：検査タイプ別、2020年～2034年
- 北米：エンドユーザー別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：製品別、2020年～2034年
- 欧州：タイプ別、2020年～2034年
- 欧州：検査タイプ別、2020年～2034年
- 欧州：エンドユーザー別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：製品別、2020～2034年
- アジア太平洋：タイプ別、2020年～2034年
- アジア太平洋：検査タイプ別、2020年～2034年
- アジア太平洋：エンドユーザー別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：製品別、2020～2034年
- 中東・アフリカ：タイプ別、2020～2034年
- 中東・アフリカ：検査タイプ別、2020年～2034年
- 中東・アフリカ：エンドユーザー別、2020年～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：製品別、2020年～2034年
- ラテンアメリカ：タイプ別、2020年～2034年
- ラテンアメリカ：検査タイプ別、2020年～2034年
- ラテンアメリカ：エンドユーザー別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第10章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携 / 協業 / 合意 / 公開

第11章企業プロファイル

Abbott
AESKU.DIAGNOSTICS
Beckman Coulter, Inc.
BIOMERIEUX
Bio-Rad Laboratories, Inc.
EUROIMMUN
F. Hoffmann-La Roche Ltd
Inova Diagnostics（Werfen Group）
Myriad Genetics, Inc.
Quest Diagnostics
Scipher Medicine
Siemens Healthcare Private Limited
Thermo Fisher Scientific Inc.

図表

List of Tables:

Table 1 Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 2 Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 3 Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 4 Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 5 North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 6 North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 7 North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 8 North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 9 US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 10 US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 11 US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 12 US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 13 Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 14 Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 15 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 16 Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 17 Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 18 Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 19 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 20 Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 21 UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 22 UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 23 UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 24 UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 25 France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 26 France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 27 France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 28 France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 29 Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 30 Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 31 Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 32 Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 33 Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 34 Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 35 Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 36 Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 37 Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 38 Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 39 Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 40 Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 41 Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 42 Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 43 Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 44 Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 45 Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 46 Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 47 Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 48 Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 49 Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 50 Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 51 Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 52 Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 53 Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 54 Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 55 Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 56 Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 57 China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 58 China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 59 China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 60 China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 61 India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 62 India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 63 India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 64 India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 65 Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 66 Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 67 Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 68 Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 69 Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 70 Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 71 Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 72 Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 73 Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 74 Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 75 Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 76 Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 77 South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 78 South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 79 South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 80 South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 81 Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 82 Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 83 Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 84 Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 85 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 86 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 87 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 88 Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 89 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 90 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 91 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 92 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 93 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 94 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 95 Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 96 Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 97 UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 98 UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 99 UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 100 UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 101 Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 102 Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 103 Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 104 Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 105 South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 106 South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 107 South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 108 South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 109 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 110 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 111 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 112 Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 113 Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 114 Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 115 Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 116 Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 117 Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 118 Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 119 Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 120 Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 121 Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 122 Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 123 Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 124 Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 125 Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 126 Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 127 Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 128 Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
Table 129 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
Table 130 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
Table 131 Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
Table 132 Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
List of Figures:
Figure 1. Global Autoimmune Disease Diagnostics Market, 2020-2034 (USD million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product
Figure 7. Global Autoimmune Disease Diagnostics Market, by Product, 2024 & 2034 (USD million)
Figure 8. Market by Type
Figure 9. Global Autoimmune Disease Diagnostics Market, by Type, 2024 & 2034 (USD million)
Figure 10. Market by Test Type
Figure 11. Global Autoimmune Disease Diagnostics Market, by Test Type, 2024 & 2034 (USD million)
Figure 12. Market by End User
Figure 13. Global Autoimmune Disease Diagnostics Market, by End User, 2024 & 2034 (USD million)

Product Code: PM1299

The global autoimmune disease diagnostics market size is expected to reach USD 7,146.32 million by 2034, according to a new study by Polaris Market Research. The report "Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The autoimmune disease diagnostics market is a sector within the healthcare and diagnostic industry. The market focuses on the identification and management of autoimmune diseases through advanced diagnostic tools and techniques. Autoimmune diseases occur when the immune system attacks the body's tissues, leading to a range of chronic and potential conditions. The market encompasses diagnostic tests and technologies used to detect these conditions, including blood tests, imaging techniques, and molecular assays.

The increasing prevalence of autoimmune diseases globally drives demand for early and accurate diagnostic tools. As awareness of these conditions grows, patients and healthcare providers seek more precise and efficient diagnostic solutions. Additionally, the rising adoption of personalized medicine and advanced treatment approaches necessitates accurate diagnostics, further boosting market growth. Government initiatives and funding for research into autoimmune diseases and diagnostics are contributing to the development of new diagnostic methods, thereby enhancing market opportunities.

In 2021, the Accelerating Medicines Partnership (AMP) program introduced the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) program. The AMP Autoimmune and Immune-Mediated Diseases (AMP AIM) initiative is driving the market by increasing awareness and promoting early screening for autoimmune diseases.

The autoimmune disease diagnostics market is experiencing swift to advanced and automated diagnostic solutions that provide higher accuracy and faster results. Integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms is transforming how autoimmune diseases are detected and monitored, improving efficiency and precision. Furthermore, there is an increasing focus on developing noninvasive diagnostic techniques, which provide a more patient-friendly alternative to traditional methods.

In July 2022, KSL Beutner Laboratories (Beutner) announced the launch of an indirect immunofluorescence (IIF) serum blood test in the US. The test effectively detects laminin 332, an antigen linked to the persistent autoimmune condition mucous membrane pemphigoid (MMP). These increasing developments in diagnostic methods drive the autoimmune disease diagnostics market growth.

Autoimmune Disease Diagnostics Market Report Highlights

Based on type, the systemic autoimmune disease diagnostics segment dominated the autoimmune disease diagnostics market revenue share, mainly attributed to increased awareness among healthcare providers and patients.

The antinuclear antibody (ANA) tests segment, by test type, is expected to register the highest CAGR during the forecast period, owing to the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.

North America dominated the market due to advanced healthcare infrastructure and substantial funding for medical research and development.

Asia Pacific is expected to register the highest CAGR during the forecast period, owing to growing healthcare sectors in countries such as China and India and the increasing prevalence of autoimmune diseases.

A few global key market players are Abbott; AESKU.DIAGNOSTICS; Beckman Coulter, Inc.; BIOMERIEUX; Bio-Rad Laboratories, Inc.; EUROIMMUN; F. Hoffmann-La Roche Ltd; Inova Diagnostics (Werfen Group); Myriad Genetics, Inc.; Quest Diagnostics; Scipher Medicine; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the autoimmune disease diagnostics market report on the basis of product, type, test type, end user, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

Consumables and Assay Kits
Instruments

By Type Outlook (Revenue - USD Million, 2020-2034)

Systemic Autoimmune Disease Diagnostics
Rheumatoid Arthritis
Ankylosing Spondylitis
Systemic Lupus Erythematosus (SLE)
Others
Localized Autoimmune Disease Diagnostics
Multiple Sclerosis
Type 1 Diabetes
Hashimoto's Thyroiditis
Idiopathic Thrombocytopenic Purpura
Others

By Test Type Outlook (Revenue - USD Million, 2020-2034)

Antinuclear Antibody (ANA) Tests
Autoantibody Tests
Complete Blood Count (CBC)
Comprehensive Metabolic Panel
C-Reactive Protein (CRP)
Others

By End User Outlook (Revenue - USD Million, 2020-2034)

Hospitals
Diagnostics Centers
Research Laboratories

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Vietnam
Malaysia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Autoimmune Disease Diagnostics Market Insights

4.1. Autoimmune Disease Diagnostics Market - Type Snapshot
4.2. Autoimmune Disease Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increased Awareness and Screening Programs
  - 4.2.1.2. Rising Healthcare Expenditure and Investments in Research
4.3. Restraints and Challenges
4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers (Moderate)
- 4.4.2. Threats of New Entrants (Low)
- 4.4.3. Bargaining Power of Buyers (Moderate)
- 4.4.4. Threat of Substitute (Moderate)
- 4.4.5. Rivalry Among Existing Firms (High)
4.5. PESTEL Analysis
4.6. Autoimmune Disease Diagnostics Market Type Trends
4.7. Value Chain Analysis
4.8. COVID-19 Impact Analysis

5. Global Autoimmune Disease Diagnostics Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
5.3. Consumables and Assay Kits
- 5.3.1. Global Autoimmune Disease Diagnostics Market, by Consumables and Assay Kits, by Region, 2020-2034 (USD million)
5.4. Instruments
- 5.4.1. Global Autoimmune Disease Diagnostics Market, by Instruments, by Region, 2020-2034 (USD million)

6. Global Autoimmune Disease Diagnostics Market, by Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
6.3. Systemic Autoimmune Disease Diagnostics
- 6.3.1. Global Autoimmune Disease Diagnostics Market, by Systemic Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.3.2. Rheumatoid Arthritis
  - 6.3.2.1. Global Autoimmune Disease Diagnostics Market, by Rheumatoid Arthritis, by Region, 2020-2034 (USD million)
- 6.3.3. Ankylosing Spondylitis
  - 6.3.3.1. Global Autoimmune Disease Diagnostics Market, by Ankylosing Spondylitis, by Region, 2020-2034 (USD million)
- 6.3.4. Systemic Lupus Erythematosus (SLE)
  - 6.3.4.1. Global Autoimmune Disease Diagnostics Market, by Systemic Lupus Erythematosus (SLE), by Region, 2020-2034 (USD million)
- 6.3.5. Others
  - 6.3.5.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)
6.4. Localized Autoimmune Disease Diagnostics
- 6.4.1. Global Autoimmune Disease Diagnostics Market, by Localized Autoimmune Disease Diagnostics, by Region, 2020-2034 (USD million)
- 6.4.2. Multiple Sclerosis
  - 6.4.2.1. Global Autoimmune Disease Diagnostics Market, by Multiple Sclerosis, by Region, 2020-2034 (USD million)
- 6.4.3. Type 1 Diabetes
  - 6.4.3.1. Global Autoimmune Disease Diagnostics Market, by Type 1 Diabetes, by Region, 2020-2034 (USD million)
- 6.4.4. Hashimoto's Thyroiditis
  - 6.4.4.1. Global Autoimmune Disease Diagnostics Market, by Hashimoto's Thyroiditis, by Region, 2020-2034 (USD million)
- 6.4.5. Idiopathic Thrombocytopenic Purpura
  - 6.4.5.1. Global Autoimmune Disease Diagnostics Market, by Idiopathic Thrombocytopenic Purpura, by Region, 2020-2034 (USD million)
- 6.4.6. Others
  - 6.4.6.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

7. Global Autoimmune Disease Diagnostics Market, by Test Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
7.3. Antinuclear Antibody (ANA) Tests
- 7.3.1. Global Autoimmune Disease Diagnostics Market, by Antinuclear Antibody (ANA) Tests, by Region, 2020-2034 (USD million)
7.4. Autoantibody Tests
- 7.4.1. Global Autoimmune Disease Diagnostics Market, by Autoantibody Tests, by Region, 2020-2034 (USD million)
7.5. Complete Blood Count (CBC)
- 7.5.1. Global Autoimmune Disease Diagnostics Market, by Complete Blood Count (CBC) , by Region, 2020-2034 (USD million)
7.6. Comprehensive Metabolic Panel
- 7.6.1. Global Autoimmune Disease Diagnostics Market, by Comprehensive Metabolic Panel, by Region, 2020-2034 (USD million)
7.7. C-Reactive Protein (CRP)
- 7.7.1. Global Autoimmune Disease Diagnostics Market, by C-Reactive Protein (CRP), by Region, 2020-2034 (USD million)
7.8. Others
- 7.8.1. Global Autoimmune Disease Diagnostics Market, by Others, by Region, 2020-2034 (USD million)

8. Global Autoimmune Disease Diagnostics Market, by End User

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
8.3. Hospitals
- 8.3.1. Global Autoimmune Disease Diagnostics Market, by Hospitals, by Region, 2020-2034 (USD million)
8.4. Diagnostics Centers
- 8.4.1. Global Autoimmune Disease Diagnostics Market, by Diagnostics Centers, by Region, 2020-2034 (USD million)
8.5. Research Laboratories
- 8.5.1. Global Autoimmune Disease Diagnostics Market, by Research Laboratories, by Region, 2020-2034 (USD million)

9. Global Autoimmune Disease Diagnostics Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Autoimmune Disease Diagnostics Market Assessment, By Geography, 2020-2034 (USD million)
9.3. Autoimmune Disease Diagnostics Market - North America
- 9.3.1. North America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.3.2. North America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.3.3. North America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.3.4. North America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.5. Autoimmune Disease Diagnostics Market - US
  - 9.3.5.1. US: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.3.5.2. US: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.3.5.3. US: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.3.5.4. US: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.3.6. Autoimmune Disease Diagnostics Market - Canada
  - 9.3.6.1. Canada: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.3.6.2. Canada: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.3.6.3. Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.3.6.4. Canada: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.4. Autoimmune Disease Diagnostics Market - Europe
- 9.4.1. Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.4.2. Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.4.3. Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.4.4. Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.5. Autoimmune Disease Diagnostics Market - UK
  - 9.4.5.1. UK: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.5.2. UK: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.5.3. UK: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.5.4. UK: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.6. Autoimmune Disease Diagnostics Market - France
  - 9.4.6.1. France: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.6.2. France: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.6.3. France: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.6.4. France: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.7. Autoimmune Disease Diagnostics Market - Germany
  - 9.4.7.1. Germany: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.7.2. Germany: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.7.3. Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.7.4. Germany: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.8. Autoimmune Disease Diagnostics Market - Italy
  - 9.4.8.1. Italy: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.8.2. Italy: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.8.3. Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.8.4. Italy: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.9. Autoimmune Disease Diagnostics Market - Spain
  - 9.4.9.1. Spain: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.9.2. Spain: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.9.3. Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.9.4. Spain: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.10. Autoimmune Disease Diagnostics Market - Netherlands
  - 9.4.10.1. Netherlands: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.10.2. Netherlands: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.10.3. Netherlands: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.10.4. Netherlands: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.11. Autoimmune Disease Diagnostics Market - Russia
  - 9.4.11.1. Russia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.11.2. Russia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.11.3. Russia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.11.4. Russia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.4.12. Autoimmune Disease Diagnostics Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.4.12.2. Rest of Europe: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.4.12.3. Rest of Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.4.12.4. Rest of Europe: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.5. Autoimmune Disease Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.5.2. Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.5.3. Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.5.4. Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.5. Autoimmune Disease Diagnostics Market - China
  - 9.5.5.1. China: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.5.2. China: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.5.3. China: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.5.4. China: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.6. Autoimmune Disease Diagnostics Market - India
  - 9.5.6.1. India: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.6.2. India: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.6.3. India: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.6.4. India: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.7. Autoimmune Disease Diagnostics Market - Malaysia
  - 9.5.7.1. Malaysia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.7.2. Malaysia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.7.3. Malaysia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.7.4. Malaysia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.8. Autoimmune Disease Diagnostics Market - Japan
  - 9.5.8.1. Japan: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.8.2. Japan: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.8.3. Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.8.4. Japan: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.9. Autoimmune Disease Diagnostics Market - Indonesia
  - 9.5.9.1. Indonesia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.9.2. Indonesia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.9.3. Indonesia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.9.4. Indonesia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.10. Autoimmune Disease Diagnostics Market - South Korea
  - 9.5.10.1. South Korea: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.10.2. South Korea: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.10.3. South Korea: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.10.4. South Korea: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.11. Autoimmune Disease Diagnostics Market - Australia
  - 9.5.11.1. Australia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.11.2. Australia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.11.3. Australia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.11.4. Australia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.5.12. Autoimmune Disease Diagnostics Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.5.12.2. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.5.12.3. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.5.12.4. Rest of Asia Pacific: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.6. Autoimmune Disease Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.6.2. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.6.3. Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.6.4. Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.5. Autoimmune Disease Diagnostics Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.5.2. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.5.3. Saudi Arabia: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.5.4. Saudi Arabia: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.6. Autoimmune Disease Diagnostics Market - UAE
  - 9.6.6.1. UAE: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.6.2. UAE: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.6.3. UAE: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.6.4. UAE: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.7. Autoimmune Disease Diagnostics Market - Israel
  - 9.6.7.1. Israel: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.7.2. Israel: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.7.3. Israel: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.7.4. Israel: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.8. Autoimmune Disease Diagnostics Market - South Africa
  - 9.6.8.1. South Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.8.2. South Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.8.3. South Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.8.4. South Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.6.9. Autoimmune Disease Diagnostics Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.6.9.2. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.6.9.3. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.6.9.4. Rest of Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
9.7. Autoimmune Disease Diagnostics Market - Latin America
- 9.7.1. Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
- 9.7.2. Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
- 9.7.3. Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
- 9.7.4. Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.5. Autoimmune Disease Diagnostics Market - Mexico
  - 9.7.5.1. Mexico: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.5.2. Mexico: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.5.3. Mexico: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.5.4. Mexico: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.6. Autoimmune Disease Diagnostics Market - Brazil
  - 9.7.6.1. Brazil: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.6.2. Brazil: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.6.3. Brazil: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.6.4. Brazil: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.7. Autoimmune Disease Diagnostics Market - Argentina
  - 9.7.7.1. Argentina: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.7.2. Argentina: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.7.3. Argentina: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.7.4. Argentina: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)
- 9.7.8. Autoimmune Disease Diagnostics Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Product, 2020-2034 (USD million)
  - 9.7.8.2. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Type, 2020-2034 (USD million)
  - 9.7.8.3. Rest of Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2020-2034 (USD million)
  - 9.7.8.4. Rest of Latin America: Autoimmune Disease Diagnostics Market, by End User, 2020-2034 (USD million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. AESKU.DIAGNOSTICS
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Beckman Coulter, Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. BIOMERIEUX
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Bio-Rad Laboratories, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. EUROIMMUN
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. F. Hoffmann-La Roche Ltd
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Inova Diagnostics (Werfen Group)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Myriad Genetics, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Quest Diagnostics
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Scipher Medicine
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Siemens Healthcare Private Limited
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Thermo Fisher Scientific Inc.
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development

自己免疫疾患診断市場、規模、シェア、動向、産業分析レポート：製品タイプ別、検査タイプ別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

自己免疫疾患診断市場のレポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の自己免疫疾患診断市場の洞察

第5章世界の自己免疫疾患診断市場：製品別

第6章世界の自己免疫疾患診断市場：タイプ別

第7章世界の自己免疫疾患診断市場：検査タイプ別

第8章世界の自己免疫疾患診断市場：エンドユーザー別

第9章世界の自己免疫疾患診断市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables:

Autoimmune Disease Diagnostics Market Report Highlights

By Product Outlook (Revenue - USD Million, 2020-2034)

By Type Outlook (Revenue - USD Million, 2020-2034)

By Test Type Outlook (Revenue - USD Million, 2020-2034)

By End User Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Autoimmune Disease Diagnostics Market Insights

5. Global Autoimmune Disease Diagnostics Market, by Product

6. Global Autoimmune Disease Diagnostics Market, by Type

7. Global Autoimmune Disease Diagnostics Market, by Test Type

8. Global Autoimmune Disease Diagnostics Market, by End User

9. Global Autoimmune Disease Diagnostics Market, by Geography

10. Competitive Landscape

11. Company Profiles

自己免疫疾患診断市場、規模、シェア、動向、産業分析レポート：製品タイプ別、検査タイプ別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Autoimmune Disease Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product, Type, Test Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

自己免疫疾患診断市場のレポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の自己免疫疾患診断市場の洞察

第5章 世界の自己免疫疾患診断市場：製品別

第6章 世界の自己免疫疾患診断市場：タイプ別

第7章 世界の自己免疫疾患診断市場：検査タイプ別

第8章 世界の自己免疫疾患診断市場：エンドユーザー別

第9章 世界の自己免疫疾患診断市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables:

Autoimmune Disease Diagnostics Market Report Highlights

By Product Outlook (Revenue - USD Million, 2020-2034)

By Type Outlook (Revenue - USD Million, 2020-2034)

By Test Type Outlook (Revenue - USD Million, 2020-2034)

By End User Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Autoimmune Disease Diagnostics Market Insights

5. Global Autoimmune Disease Diagnostics Market, by Product

6. Global Autoimmune Disease Diagnostics Market, by Type

7. Global Autoimmune Disease Diagnostics Market, by Test Type

8. Global Autoimmune Disease Diagnostics Market, by End User

9. Global Autoimmune Disease Diagnostics Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の自己免疫疾患診断市場の洞察

第5章世界の自己免疫疾患診断市場：製品別

第6章世界の自己免疫疾患診断市場：タイプ別

第7章世界の自己免疫疾患診断市場：検査タイプ別

第8章世界の自己免疫疾患診断市場：エンドユーザー別

第9章世界の自己免疫疾患診断市場：地域別

第10章競合情勢

第11章企業プロファイル